You just read:

Can-Fite Files Clinical Trial Application in Canada for Piclidenoson Ahead of Upcoming Acrobat Rheumatoid Arthritis Phase III Study

News provided by

Can-Fite BioPharma Ltd.

May 16, 2017, 07:00 ET